Why the primary cancer record decides the brain question
Brain metastases are not a single disease. They are cancer that has spread to the brain from somewhere else, and the treatment logic depends heavily on where it came from. A lung cancer that has spread to the brain, a breast cancer that has spread to the brain, and a melanoma that has spread to the brain can all produce similar-looking lesions on imaging, but the systemic options, the role of targeted therapy or immunotherapy, and the expected behaviour over time differ.
If the pathology report from the original tumour is missing, a specialist reading only a brain MRI can describe the lesions but cannot reliably connect them to a known primary. That leaves the most basic question unanswered: which cancer are we actually treating?
The practical consequence is that a Chinese team may be able to offer a records-based opinion on the brain imaging alone, but it will be a partial opinion. It can comment on the number, size and location of lesions and on whether they look amenable to a local approach. It cannot responsibly recommend a systemic strategy without knowing the primary tumour type and its molecular profile.
This is why the first records to gather are not the brain scans but the original cancer file: the pathology report, the date of the original diagnosis, the site of the primary tumour, and any molecular or genomic testing that was done on the primary or on a metastasis.
What previous brain treatment changes about the next decision
A second common gap is the history of brain-directed treatment. If the patient has already had whole-brain radiotherapy, stereotactic radiosurgery, surgery, or a combination, the next clinician needs to know exactly what was done, when, to which lesions, and with what result. Without that, a new plan can accidentally repeat treatment to an area that has already received its tolerance, or miss the fact that a lesion has already been controlled.
Radiotherapy is one of the main ways brain metastases are treated, and the technique and schedule depend on the individual treatment plan. That is not a detail that can be reconstructed from a radiology report alone. The radiotherapy summary or discharge letter usually records the target, the technique and the number of sessions, and it is the document a new team will ask for.
If the prior treatment was surgery, the operative note and the pathology from the removed lesion matter. If it was systemic therapy, the drug names, dates, doses and the reason for stopping are the relevant facts. A scan that shows a lesion is smaller than before does not by itself tell the next team whether that was radiotherapy, surgery, systemic therapy or natural variation.
The unanswered question here is not 'what does the scan show' but 'what has already been done to this brain, and what does that leave open'. A missing treatment history can make a specialist cautious about recommending anything until the gap is filled.
The current systemic therapy picture
Brain metastases are usually managed alongside systemic treatment for the underlying cancer, not in isolation. If the current systemic regimen is unclear, the specialist cannot judge interactions, timing or whether a brain-directed option should be sequenced before, after or alongside it.
The relevant records are the current medication list with start dates, the most recent infusion or oral therapy records, any recent dose changes and the reason for them, and the most recent staging scans outside the brain. A list that says 'chemotherapy' without drug names is not enough. A list that names the drugs but not the dates is better but still incomplete.
This is also where a missing record can create a false impression. If a patient has stopped a drug because of side effects and that is not documented, a new team may assume the cancer progressed on that drug and rule out a class of options that is still available. Conversely, if a drug was stopped because of progression and that is not documented, a new team may propose something that has already failed.
The question to answer before an enquiry is therefore: what is being taken now, what was taken before, and why did each change happen? If the patient cannot answer that from memory, the oncology notes or the pharmacy records are the place to look.
What a records-based opinion can and cannot settle
A remote records review can be genuinely useful. It can identify whether the imaging is adequate, whether the pathology is complete, whether prior treatment has been documented, and what additional information a Chinese specialist would want before forming a view. It can also flag that a case is complex enough to need more than one specialty looking at it.
It cannot, however, establish hospital acceptance, confirm that a specific treatment is available, or replace an in-person assessment. A specialist reviewing records from a distance is working with a snapshot. Suitability for a particular procedure or systemic option is decided by the treating team after it has the full picture and, in many cases, after seeing the patient.
This distinction matters for planning. A records-based opinion is a way to find out what is missing and what the realistic next step is. It is not a booking confirmation, and it is not a guarantee that the same plan will be offered once the patient is in China.
If the goal is to understand whether travelling to China is worth considering, the most useful first step is a short summary of the case plus the key documents, not a complete archive. The gaps that remain after that summary are exactly the questions the article is about.
The specific records that close the most important gaps
If you are preparing an enquiry about brain metastases, the following items answer the three questions above. They are not a universal prerequisite list, and the receiving clinician may ask for more or less depending on the case.
Primary cancer pathology report, including the original diagnosis date and tumour type.
Molecular or genomic testing reports from the primary tumour or any metastasis, if performed.
Brain imaging reports and, where possible, the actual images, not only the written report.
Any prior brain-directed treatment summary: radiotherapy, surgery or both, with dates and targets.
Current and prior systemic therapy records, with drug names, dates and reasons for changes.
Most recent staging imaging outside the brain and the most recent clinic letter or discharge summary.
A short, plain-language summary of the patient's current symptoms and functional status, written by the patient or family if no recent clinical note exists.
How to ask a Chinese provider about the gaps
The most useful question is not 'can you treat this' but 'what is missing from this file that would change your view'. That question invites a specific answer and tells you what to collect next.
When you contact a hospital or a coordination service, describe the case in a few lines: the primary cancer, the date of diagnosis, the brain treatment already given, the current systemic therapy, and the main question. Then ask which documents the team needs to answer that question. If the reply is a general request for 'all records', ask which specific items are essential and which are optional.
It is also reasonable to ask how the team handles records in another language, whether imaging can be uploaded rather than couriered, and whether a preliminary reply is possible before a full file is assembled. These are practical questions, and the answers vary by provider.
For a case involving radiotherapy planning, the relevant reference page is precision radiotherapy, which explains the general scope of that service. It is a starting point for understanding the service, not a substitute for a case-specific opinion.
An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability, and a records review does not establish that a particular treatment is available or appropriate. If symptoms are worsening, local urgent assessment takes priority over an overseas enquiry.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.